Canrenone (Aldadiene) is an aldosterone antagonist extensively used as a diuretic agent.
性状
Solid
IC50 & Target[1][2]
Target: Aldosterone
体外研究(In Vitro)
Canrenone inhibits the production of eortieosterone, 18-hydroxydesoxyeortieosterone, 18-hydroxycorticosterone and aldosterone in a dose-dependent manner. Canrenone dose-dependently reduces platelet-derived growth factor–induced cell proliferation and motility. Canrenone inhibits the activity of the Na/H exchanger 1 induced by platelet-derived growth factor.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Canrenone is the principal active metabolite of Spironolactone in the rat only for a limited period. During chronic treatment a difference developed between the effect of Spironolactone and Canrenone on the RAAS indicating a decrease in the anti-mineralocorticoid activity of Canrenone and an increase in the efficacy of Spironolactone.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years; 4°C; 2 years;
ClinicalTrial
结构分类
Steroids
溶解度数据
体外研究:DMSO : ≥ 100 mg/mL(293.72 mM)*≥ means soluble, but saturation unknown. 配制储存液